Skip to main content
Fig. 9 | BMC Genomic Data

Fig. 9

From: Analysis of transcriptomic data sets supports the role of IL-6 in NETosis and immunothrombosis in severe COVID-19

Fig. 9

Temporal change in IL-6 expression differs between severe and moderate COVID-19 disease. Box plot shows temporal change in plasma IL-6 level in control and patients with (moderate and severe) COVID-19 illness. At the early time points, IL-6 level is higher in the cases with severe illness compared to the cases with moderate illness. At the later time points, the level of IL-6 approaches that in the cases with moderate illness. Data were extracted from [17]

Back to article page